Real-World Safety and Effectiveness of Controlled-Release Cilostazol in Patients with Symptomatic Peripheral Artery Disease

Shin, WY; Lee, HJ; Kim, JH

Kim, JH (通讯作者),Chung Ang Univ, Coll Med, Dept Family Med, Heukseok Ro 102, Seoul 06973, South Korea.

CLINICAL DRUG INVESTIGATION, 2023; ():

Abstract

Background Cilostazol is the only first-line medication for treating intermittent claudication, and the controlled-release (CR) formulation is associa......

Full Text Link